SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

MAPLIGHT THERAPEUTICS - Q3 NET LOSS $51.60 MLN, Q3 NET LOSS PER SHARE $0.97

MPLT

Related stories